Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Charles Schwab Corp.

WKN: 874171 / Symbol: SCHW / Name: Charles Schwab / Stock / Investment Banking & Investment Services / Large Cap /

€94.06
0.020%

Charles River Labs Intl

WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Stock / Biotechnology & Medical Research / Mid Cap /

€249.70
1.690%

Charles Schwab Corp.

WKN: A3DH7S / Name: Charles Schwab Corp. / Stock / ? /

€13.40
-4.290%

Charles & Colvard Ltd.

WKN: A40D1Y / Name: Charles & Colvard Ltd. / Stock / ? /

€1.98
-

Charles Schwab Corp.

WKN: A417YL / Name: Charles Schwab Corp. / Stock / ? /

?
0.000%

Charles Schwab Corp.

WKN: A286PF / Name: Charles Schwab Corp. / Stock / ? /

€93.14
-

Charles Schwab Corp.

WKN: A3KNM1 / Name: Charles Schwab Corp. / Stock / ? /

€99.77
-0.050%

Charles + Colvard Ltd.

WKN: 923940 / Name: Chrles Clvrd / Stock / Textiles & Apparel / Micro Cap /

€0.20
-6.600%

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $3.02 per share, beating the Zacks Consensus Estimate of $2.72 per share. This compares to earnings of $3.12 per share a year

Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Charles River Laboratories (CRL) is a stock that can certainly grab the attention

Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Charles River Laboratories (CRL) reported revenue of $1 billion, down 2.7% over the same period last year. EPS came in at $3.02, compared to $3.12 in the year-ago

Charles River Associates Q2 Earnings Call Highlights
Charles River Associates Q2 Earnings Call Highlights

Key Points

International Markets and Charles River (CRL): A Deep Dive for InvestorsPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
International Markets and Charles River (CRL): A Deep Dive for Investors

Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this medical research equipment

Why Is Charles Schwab (SCHW) Up 10% Since Last Earnings Report?
Why Is Charles Schwab (SCHW) Up 10% Since Last Earnings Report?

It has been about a month since the last earnings report for The Charles Schwab Corporation (SCHW). Shares have added about 10% in that time frame, outperforming the S&P 500.

But investors have to

CharlesCek
Zehnmal angemeldet

charlesgbrock
Account activated

CharlesMouch
Account activated

Charlesteala
Account activated

Charlesambig
Account activated